Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
Status:
Recruiting
Trial end date:
2024-03-20
Target enrollment:
Participant gender:
Summary
Along with the current clinical trial, the efficacy and safety of ticagrelor and aspirin
administered within the first 24 hours of first-ever ischemic stroke compared to cilostazol
and aspirin were assessed through NIHSS, mRS, and possible adverse effects.